Generex Submits Oral Insulin Phase III Trial Dossier to Indian Government

Canada’s Generex Biotechnology, through its Indian licensee Shreya Life Sciences, has submitted a dossier of recently concluded Phase III trial results of its oral insulin “Generex Oral-lyn” to the Indian government for approval.
Pharmaceutical Business Review